+
Rosatom Scientists Patent Tech for Separating Radium, Actinium, Thorium
ECONOMY & POLICY

Rosatom Scientists Patent Tech for Separating Radium, Actinium, Thorium

The technology developed by nuclear scientists has enabled the production of actinium-225 that has a wide application in atomedics. Specialists from the Department of Radionuclide Sources and Preparations at the Research Institute of Nuclear Reactors, State Scientific Centre (RIAR JSC belongs to Rosatom’s Scientific division) have obtained a patent for the technology of producing an actinium-225-based radioactive preparation.

Due to its unique properties, the isotope is deemed promising for use in the nuclear medicine and cancer therapy. The production technology ensures the product's high quality, as evidenced during all mandatory stages of monitoring of its specifications. Nowadays, alpha emitters, such as atinium-225, are regarded as one of the most promising areas in the atomedics. These isotopes are often referred to as "the future of cancer treatment". Rosatom and healthcare facilities are actively working in this field.

"Obtaining a patent is a significant milestone for the institute, one of the four global producers of actinium-225. This new development allowed the company, which ranks among the top three at Rosatom, to strengthen its position as an innovation leader. It is also significantly contributing to the advancements in the domestic science," said Andrey Shikunov, Deputy Director for Development and International Business at RIAR JSC.

The technology was developed by Dimitrovgrad scientists under an agreement with the Ministry of Industry and Trade of the Russian Federation. The Ministry granted the company a subsidy for scientific research and development following the competitive selection process.

The technology developed by nuclear scientists has enabled the production of actinium-225 that has a wide application in atomedics. Specialists from the Department of Radionuclide Sources and Preparations at the Research Institute of Nuclear Reactors, State Scientific Centre (RIAR JSC belongs to Rosatom’s Scientific division) have obtained a patent for the technology of producing an actinium-225-based radioactive preparation. Due to its unique properties, the isotope is deemed promising for use in the nuclear medicine and cancer therapy. The production technology ensures the product's high quality, as evidenced during all mandatory stages of monitoring of its specifications. Nowadays, alpha emitters, such as atinium-225, are regarded as one of the most promising areas in the atomedics. These isotopes are often referred to as the future of cancer treatment. Rosatom and healthcare facilities are actively working in this field. Obtaining a patent is a significant milestone for the institute, one of the four global producers of actinium-225. This new development allowed the company, which ranks among the top three at Rosatom, to strengthen its position as an innovation leader. It is also significantly contributing to the advancements in the domestic science, said Andrey Shikunov, Deputy Director for Development and International Business at RIAR JSC. The technology was developed by Dimitrovgrad scientists under an agreement with the Ministry of Industry and Trade of the Russian Federation. The Ministry granted the company a subsidy for scientific research and development following the competitive selection process.

Next Story
Infrastructure Energy

INC WMC Meet Charts Greener Mine Closure Path

The Indian National Committee of the World Mining Congress (INC WMC) has wrapped up its international conference on “Sustainable and Responsible Mining through Best Mine Closure Practices” in Hyderabad. The gathering drew policymakers, industry leaders, environmental specialists, academics and other stakeholders from India and abroad to exchange global expertise on responsible mine shutdowns.Union Coal and Mines Minister G. Kishan Reddy, the event’s patron, outlined a vision for a greener, safer mining future and reaffirmed government backing for rigorous environmental standards. Sen..

Next Story
Infrastructure Urban

PM Modi Receives Trinidad & Tobago’s Top Civilian Honour

Prime Minister Narendra Modi has been conferred with the "Order of the Republic of Trinidad & Tobago," the Caribbean nation’s highest civilian honour, during a special ceremony held at the President’s House in Port of Spain. President H.E. Christine Carla Kangaloo ORTT awarded the distinction in recognition of PM Modi’s statesmanship, leadership on Global South issues, and his contribution to advancing ties between India and Trinidad & Tobago.He is the first foreign leader ever to receive this prestigious award. Accepting it on behalf of 1.4 billion Indians, the Prime Minister ..

Next Story
Infrastructure Transport

Gadkari Unveils Green Mobility Plan With New Tech, Faster Roads

Union Minister Nitin Gadkari has outlined an ambitious blueprint for next-generation mobility, featuring electric rapid transport, ropeways, hyperloop systems, cable-run buses and funicular railways to transform both urban and remote travel in India. Speaking to PTI, the Minister for Road Transport and Highways said that over 360 ropeway and funicular projects are planned nationwide, with 60 already under way—including in hilly terrains like Kedarnath.The government aims to upgrade 25,000 km of two-lane roads into four-lane highways and scale road construction to 100 km per day. “We’re i..

Advertisement

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Advertisement

Talk to us?